Turner Capital, Inc. – Trademark Portfolio
Entity Type: 03
Turner Capital, Inc. holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 10 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 3 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include DERMAGLOVE, AQUA-GREEN-CLEAN, and SKIN VITALITY...WHERE THERAPY MEETS HYGIENE. The owner is based in Atlanta, GA.
2328 Colonial Dr. Atlanta
Atlanta, GA 30319
Showing of trademarks Trademarks
Trademark Classifications
Turner Capital, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Turner Capital, Inc. have?
Turner Capital, Inc. has 10 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 abandoned, 6 cancelled.
What trademark classes does Turner Capital, Inc. file in?
Turner Capital, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 1 (Chemicals). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.
What are Turner Capital, Inc.'s most well-known trademarks?
Turner Capital, Inc.'s registered trademark portfolio includes well-known marks such as DERMAGLOVE, AQUA-GREEN-CLEAN, and SKIN VITALITY...WHERE THERAPY MEETS HYGIENE. These are among 3 currently registered trademarks in the portfolio.
What is Turner Capital, Inc.'s trademark registration success rate?
Turner Capital, Inc. has a 30% trademark registration rate, with 3 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.